ExpreS²ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the 2023 first quarter interim results and answer investors’ questions. More information and registration can be found on the
H.C. Andersen Capital Events website.

ExpreS²ion CEO Bent Frandsen will present ExpreS²ion to investors and potential investors. Registration is possible via the event website

ExpreS²ion pre-clinical development partner University of Bologna will present “Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis.” More information and registration can be found on the AACR website

University of Bologna ES2B-C001 poster from AACR

ExpreS²ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the 2023 Rights Issue and answer investors' questions about how to participate. More information and registration can be found on the H.C. Andersen Capital Events website

ExpreS²ion CFO Keith Alexander will present ExpreS²ion to investors and potential investors. Registration is possible via the Swiss Nordic Bio website

ExpreS²ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the 2022 fourth quarter and full-year results and answer investors’ questions. More information and registration can be found on the
H.C. Andersen Capital Events website.

An opportunity for investors and potential partners to meet CEO Bent U. Frandsen and CFO Keith Alexander in 1-on-1 meetings.

Find more information on J.P. Morgan’s website.

The Biotech Showcase is being held 9-11 January at the Hilton San Francisco Union Square, in San Francisco, California, USA. CEO Bent Frandsen will present the Company at 9:30 am PST on Wednesday January 11th, 2023, at the event and both CEO Bent Frandsen and CFO Keith Alexander will take meetings with potential partners and investors. Registration is possible via the Biotech Showcase website.

Presentation and Q&A with CEO Bent Frandsen. Register to participate and ask questions on H.C. Andersen Capital's Event website.

CEO Bent U. Frandsen will present ExpreS²ion to investors and potential investors. Registration is possible via
BioStock website.

ExpreS²ion CEO, Bent U. Frandsen and CFO Keith Alexander will discuss the Q3 2022 results and answer investors’ questions. More information and registration can be found on the
H.C. Andersen Capital Events website.

Meet ExpreS²ion’s VP of R&D and Technology, Dr. Max M. Søgaard at the largest protein & antibody engineering event in Europe. More information and registration can be found on the PEGS Europe website.

CFO Keith Alexander will present ExpreS²ion to investors and potential investors. Registration is possible via Vator Securities.

CEO of ExpreS²ion Biotechnologies Bent U. Frandsen will present the company at the Økonomisk Ugebrev, Life Science Investor Conference in Copenhagen. It is possible to attend the meeting by registering on the event website.

Come and meet ExpreS²ion CEO at The Nordic Growth Summit at Innovation Centre Denmark where CEO Bent U. Frandsen will be both participating and available for meetings. Read more and sign up on the BBLSA Website .

Meet ExpreS²ion’s VP of Preclinical Development, Dr. Mette Thorn, and hear the company’s preclinical development partners from the University of Bologna present on "Prevention and therapy of metastatic HER-2+ mammary carcinoma with a human candidate HER-2 virus-like particle vaccine,” in a forum covering the most recent advances in the field of cancer immunotherapy. More information and registration can be found on the PIVAC-22 website.

Join CEO of ExpreS²ion Biotechnologies Bent U. Frandsen for a live update at Aktiedagen in Lund. You can stream the event live or on demand via Aktiespararnas YouTube Channel. or at aktiespararna.se/tv/live.

An opportunity for investors and potential partners to meet ExpreS²ion CEO Bent U. Frandsen and CFO Keith Alexander in 1-on-1 meetings. More information and registration can be found on the LSX Nordic website .

ExpreS²ion CEO, Bent U. Frandsen and CFO Keith Alexander will discuss the Q2 2022 results and answer investors’ questions. More information and registration can be found on the
H.C. Andersen Capital Events website.

Meet ExpreS²ion CEO, Bent Frandsen, at the largest global biotechnology industry event. More information and registration can be found on the BIO website.

Meet our scientists at the leading conference focused on the discovery, development and manufacture of vaccines, hosted by ECI. More information and registration can be found on the ECI website.  

ExpreS²ion CEO Bent U. Frandsen will discuss the Q1 2022 results and answer investors’ questions. More information and registration can be found on the H.C. Andersen Capital events website.

ExpreS²ion VP of Preclinical Development Mette Thorn and CFO Keith Alexander will provide an update on ExpreS²ion’s HER2+ therapeutic breast cancer vaccine program and answer participants’ questions. More information and registration can be found on the H.C. Andersen Capital events website.

The Nordic Health Summit Japan is a partnering and investor conference aimed at connecting Nordic healthcare innovations with Japanese investors industry and ecosystems. Come meet CEO Bent U. Frandsen in 1-on-1 virtual meetings. Please visit the event website for more information and to register.

Meet with ExpreS²ion’s CMO, Mattis Flyvholm Ranthe, and VP of Preclinical Development, Mette Thorn, at 2022 ESMO Breast Cancer meeting. More information and registration can be found on the ESMO website.

Meet virtually with ExpreS²ion’s VP of R&D and Technology, Max Søgaard, at the leading international meeting for the biotherapeutics community. More information and registration can be found on the PEGS Summit website.

See the company presentation by our CEO Bent U. Frandsen at this investor event. It is possible to attend the meeting by reserving a seat on the event website.

ExpreS²ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the 2022 Rights Issue and answer investor’s questions about how to participate. More information and registration can be found on the H.C. Andersen Capital events website.

Meet in-person with ExpreS²ion’s CMO, Mattis Flyvholm Ranthe at the largest, most established meeting dedicated to vaccines. More information and registration can be found on the World Vaccine Congress website.

To pre-arrange business meetings with ExpreS2ion representatives, please contact us via email on info@expreS2ionbio.com. More information is available at BIO-Europe’s website.

To pre-arrange investor/business meetings with our CEO Bent U. Frandsen, please contact us via email on info@expreS2ionbio.com. Bent will also present ExpreS²ion on a panel from 12:15 to 12:55 local time in Room: Zurich 1. More information is available at the event website Swiss Nordic Bio.

Join CEO Bent Frandsen for a live update at Aktiespararna’s Stora Aktiedagen in Stockholm. You can stream the event live or on demand via Aktiespararnas YouTube channel or aktiespararna.se/tv/live. Read more here.

While focusing on the cutting edge of recombinant protein production and characterisation we are also on the lookout for collaboration opportunities.
Read more and register here

Presentation and Q&A with CEO Bent Frandsen.
Register to participate and ask questions here.

Join CEO Bent Frandsen for a live update at Aktiespararna’s Stora Aktiedagen in Stockholm.
Read more here

CEO Bent Frandsen and CFO Keith Alexander will present Q3 2021 financial results.
Register to participate and ask questions here.

An opportunity for investors and potential partners to meet ExpreS2ion management in 1-on-1 virtual meetings.
Find more information on Jefferies website.

An opportunity for investors and potential partners to meet ExpreS2ion management in 1-on-1 virtual meetings.
Find more information and register on LSX Leader's website

While focusing on the cutting edge of recombinant protein production and characterisation we are also on the lookout for collaboration opportunities.

Read more and register here. 

Read more and register now

Read more about World Vaccine Congress here and come meet us at booth 27 in Barcelona

Join CEO Bent Frandsen in taking a dive deeper into the economy and the potential for ExpreS2ion on their Coronavirus vaccine candidate, including milestones and license royalty payments.
Register on HC Andersen Capital's website

CEO Bent Frandsen will present ExpreS2ion to investors and potential investors. Sign up available on Dansk Aktionærforening's website

Come see CEO Bent Frandsen's latest investor presentation. Sign up here.

CEO Bent Frandsen will make a live presentation viewable on Aktiespararna's YouTube channel at 11:00 CET

An opportunity for investors and potential partners to meet ExpreS2ion management in a 1-on-1 virtual meeting. Read more and register now.

Meet our Vice President R&D Max Søgaard who'll be talking about fast-track development of the SARS-CoV-2 Subunit Vaccine at 14:05 CET.
Read more and register now

CEO Bent Frandsen and CFO Keith Alexander will present Q2 2021 financial results. Register to participate and ask questions here.

CEO Bent Frandsen will make a presentation at 16:00 CET (10:00 ET). Read more and sign up here: LifeSci Advisors Nordic Biotech Summit 2021

CEO Bent Frandsen will make a presentation at 09:20.
Read more and sign up here: Life Science Seminar

Max Soegaard, VP of R&D and Technology at ExpreS2ion Bio, presents experiences from the fast-track development of the SARS-CoV-2 subunit vaccine.

CEO Bent U. Frandsen will make a presentation about ExpreS2ion Biotech at 11.00hrs. CET. Watch presentation here.

CEO Bent U. Frandsen will make a presentation about ExpreS2ion Biotech at 11.30hrs. CET on Nov. 17. Watch presentation here.

https://www.eventbrite.co.uk/e/life-science-investor-konference-tickets-117381831217